• LAST PRICE
    34.0700
  • TODAY'S CHANGE (%)
    Trending Down-0.8000 (-2.2942%)
  • Bid / Lots
    33.3600/ 1
  • Ask / Lots
    34.7900/ 1
  • Open / Previous Close
    34.6900 / 34.8700
  • Day Range
    Low 34.0100
    High 35.0300
  • 52 Week Range
    Low 23.0450
    High 35.5600
  • Volume
    377,694
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 34.87
TimeVolumeSUPN
09:32 ET112834.48
09:34 ET70034.47
09:38 ET140534.66
09:39 ET102434.61
09:41 ET21734.82
09:45 ET50034.705
09:48 ET10034.7
09:56 ET10034.45
10:03 ET36434.355
10:06 ET20034.355
10:08 ET10034.355
10:12 ET30034.455
10:14 ET10034.455
10:17 ET59034.37
10:26 ET50034.11
10:28 ET10034.12
10:30 ET30034.19
10:42 ET90034.13
10:44 ET88734.015
10:46 ET250034.045
10:48 ET2269534.0289
10:50 ET60434.11
10:51 ET70034.31
10:53 ET20034.295
10:55 ET70034.26
10:57 ET40034.2
11:00 ET10034.195
11:02 ET110034.25
11:04 ET40034.255
11:06 ET167534.3
11:08 ET32234.3
11:09 ET310034.45
11:11 ET10034.485
11:15 ET20034.52
11:20 ET10034.57
11:24 ET76034.58
11:26 ET20034.58
11:29 ET20034.58
11:31 ET20034.58
11:33 ET20034.58
11:38 ET30034.585
11:40 ET10034.65
11:42 ET10034.58
11:44 ET90034.695
11:45 ET10034.7
11:47 ET74534.775
11:49 ET10034.86
11:51 ET215534.72
11:54 ET30034.79
11:58 ET60034.92
12:00 ET40034.92
12:02 ET268234.95
12:03 ET30034.95
12:07 ET37734.99
12:09 ET80034.86
12:12 ET20034.9
12:16 ET20034.865
12:20 ET30034.865
12:21 ET60034.925
12:23 ET30034.95
12:30 ET90034.9
12:32 ET10034.91
12:36 ET20034.88
12:38 ET20034.88
12:39 ET70034.8025
12:41 ET10034.785
12:43 ET20034.78
12:45 ET102234.74
12:52 ET10034.65
12:56 ET30034.615
12:57 ET10034.615
12:59 ET70034.59
01:01 ET30034.61
01:03 ET101234.65
01:06 ET50034.65
01:08 ET112334.562
01:10 ET40034.5
01:12 ET270634.56
01:17 ET30034.61
01:19 ET60034.54
01:21 ET10034.49
01:32 ET10034.53
01:37 ET10034.48
01:39 ET20034.48
01:42 ET10034.45
01:44 ET10034.47
01:48 ET280034.405
01:50 ET40034.44
01:51 ET80034.46
01:57 ET230034.43
02:00 ET208734.46
02:02 ET20034.47
02:04 ET40034.46
02:06 ET30034.46
02:08 ET160034.435
02:09 ET90034.455
02:13 ET784034.41
02:15 ET115834.31
02:20 ET20034.275
02:29 ET56234.31
02:31 ET407934.21
02:33 ET20034.22
02:38 ET30034.16
02:40 ET10034.2
02:42 ET159034.19
02:44 ET20034.23
02:45 ET30034.225
02:47 ET50034.27
02:49 ET20034.295
02:51 ET40834.27
02:54 ET658734.35
02:56 ET202034.3
02:58 ET11634.2835
03:00 ET30034.28
03:02 ET60034.32
03:07 ET80134.22
03:09 ET103334.205
03:12 ET10434.23
03:14 ET30034.21
03:16 ET30034.25
03:18 ET27434.28
03:20 ET292934.21
03:21 ET2203334.25
03:25 ET70034.3
03:27 ET20034.36
03:30 ET50034.36
03:32 ET70034.41
03:34 ET30034.41
03:36 ET30034.38
03:38 ET20034.42
03:39 ET334034.3
03:41 ET247534.24
03:43 ET40034.23
03:45 ET60034.215
03:48 ET40034.21
03:50 ET110034.225
03:52 ET177034.21
03:54 ET141434.2
03:56 ET323434.135
03:57 ET299234.095
03:59 ET7125834.07
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSUPN
Supernus Pharmaceuticals Inc
1.9B
385.7x
-59.02%
United StatesPAHC
Phibro Animal Health Corp
959.9M
388.3x
-46.35%
United StatesEGRX
Eagle Pharmaceuticals Inc
6.5M
0.7x
-4.75%
United StatesSGTI
Shengtai Pharmaceutical Inc
10.0
0.0x
---
United StatesSHWZ
Medicine Man Technologies Inc
6.2M
---
---
United StatesELTP
Elite Pharmaceuticals Inc
464.7M
23.2x
---
As of 2024-10-31

Company Information

Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson’s Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The Company is also developing a range of novel CNS product candidates, including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. Its commercial products, including Qelbree (viloxazine), GOCOVRI (amantadine), Oxtellar XR (oxcarbazepine), Trokendi XR (topiramate), APOKYN (apomorphine hydrochloride injection) and others. Qelbree (viloxazine) is a novel non-stimulant product indicated for the treatment of ADHD.

Contact Information

Headquarters
9715 Key West AvenueROCKVILLE, MD, United States 20850
Phone
301-838-2500
Fax
302-636-5454

Executives

Independent Chairman of the Board
Charles Newhall
President, Chief Executive Officer, Secretary, Director
Jack Khattar
Chief Financial Officer, Senior Vice President
Timothy Dec
Senior Vice President - Intellectual Property, Chief Scientific Officer
Padmanabh Bhatt
Senior Vice President - Quality, GMP Operations and Information Technology and Regulatory Affairs
Frank Mottola

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9B
Revenue (TTM)
$630.2M
Shares Outstanding
55.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$0.09
Book Value
$16.84
P/E Ratio
385.7x
Price/Sales (TTM)
3.0
Price/Cash Flow (TTM)
21.3x
Operating Margin
4.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.